血漿蛋白製剤の世界市場規模調査＆予測、製品タイプ別、用途別、地域別分析、2022-2029年

血漿蛋白製剤の世界市場は、2021年に約274億5,000万米ドルと評価され、予測期間2022-2029年には7%以上の健全な成長率で成長すると予測されています。

血漿蛋白製剤は、血漿からなる生物学的医薬品です。血漿は、製造・加工方法によって異なる化学組成を持つ生体物質です。血液の大部分は血漿でできており、水分、塩分、タンパク質、抗体、酵素を含んでいます。血漿蛋白製剤市場は、免疫不全疾患の発生率の増加や老年人口の急増などの要因によって拡大しています。血漿蛋白製剤市場は、免疫不全疾患の増加や老年人口の増加などの要因により拡大しています。

血漿蛋白製剤は、様々な慢性疾患、生命を脅かす疾患、遺伝性疾患の治療に使用されています。その普及率は、ここ数年、徐々に増加しています。Statistaによると、世界中の血漿需要は2020年までに最大5,000万リットルまで増加すると予想されています。さらに、2020年には、1018.8メートルトンのアルブミンが世界中で消費され、2022年には約1125.5メートルトンに達すると予測されています。がん診断や治療、モーバス・ウィルソン治療に使用される血漿から生成される世界のタンパク質です。主にがんの診断や治療に使用されています。スペースを牽引するもう一つの重要な要素は、老年人口の増加です。2022年、モナコは65歳以上の総人口の割合が最も高い国でした。モナコは、65歳以上の日本人の割合が36％と、世界で最も高齢化が進んでいます。一方、ドイツは2022年に65歳以上の人口が22%になります。また、世界の人口の約25％が15歳未満で、10％が65歳以上です。世界で最も若い人口はアフリカにいます。平均寿命が短い国も多く、15歳未満の人口は40％、65歳以上の人口は4％未満です。一方、欧州では、65歳以上の人口が15歳未満の人口を上回っています。さらに、2021年にはバクスター・インターナショナル社が「PrisMax 2」の世界発売を発表しました。これは、持続的腎代替療法および臓器支持血漿療法の提供を簡素化し、集中治療室の需要に対応する柔軟性を提供するように設計されています。PrisMax 2は、当社のTrueVueデジタルヘルス・ポートフォリオと、急性呼吸機能障害をサポートする体外式炭酸ガス除去療法を提供するPrismaLung血液ガス交換器を備えています。しかし、血漿蛋白製剤の高コストが、2022-2029年の予測期間を通じて市場成長を阻害しています。

血漿蛋白製剤の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、ヘルスケア支出の増加により、収益面で優位を占めています。Statistaによると、北米のヘルスケア分野は2023年に207億7,000万米ドルに達すると予測され、2023年から2027年にかけて12.25%の年間成長率を示し、2027年の予測市場規模は329億7,000万米ドルに達すると予想されています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • 血漿蛋白製剤市場、地域別、2019-2029年
  • 血漿蛋白製剤市場、製品タイプ別、2019-2029年
  • 血漿蛋白製剤市場、用途別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 世界の血漿蛋白製剤市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 血漿蛋白製剤の世界市場力学

• 血漿蛋白製剤市場のインパクト分析（2019-2029年）
  • 市場促進要因
    • 免疫不全疾患の発生率の増加
    • 老年人口の急増
  • 市場の課題
    • 血漿蛋白製剤の高コスト化
  • 市場機会
    • 製薬会社による研究開発プログラムへの投資の増加

第4章 世界の血漿蛋白製剤市場産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 主な投資機会
• 主要成功戦略
• 業界関係者見通し
• アナリストの提言と結論

第5章 リスク評価：COVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 血漿蛋白製剤の世界市場：製品タイプ別

• マーケットスナップショット
• 血漿蛋白製剤の世界市場：製品タイプ別、実績 - ポテンシャル分析
• 血漿蛋白製剤の世界市場製品タイプ別推定・予測2019-2029
• 血漿蛋白製剤市場、サブセグメント分析
  • C1エステラーゼインヒビター
  • アルブミン
  • 免疫グロブリン
  • その他

第7章 血漿蛋白製剤の世界市場：用途別

• マーケットスナップショット
• 血漿蛋白製剤の世界市場：用途別、実績 - ポテンシャル分析
• 血漿蛋白製剤の世界市場推定・予測（アプリケーション別） 2019-2029
• 血漿蛋白製剤市場、サブセグメント分析
  • 遺伝性血管性浮腫
  • 血友病
  • げんぱつせいめんえきふぜんしょう
  • その他

第8章 血漿蛋白製剤の世界市場：地域別分析

• 血漿蛋白製剤市場、地域別マーケットスナップショット
• 北米
  • 米国
    • 製品タイプ別の推定・予測、2019年～2029年
    • アプリケーション別の推定・予測、2019年～2029年
  • カナダ
• 欧州血漿蛋白製剤市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋血漿蛋白製剤市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ血漿蛋白製剤市場スナップショット
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域
• 世界のその他の地域

第9章 競合情報

• トップ市場戦略
• 企業プロファイル
  • Baxter International
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Biotest
  • CSL Behring
  • China Biologics
  • GRIFOLS, S.A.
  • Kedrion
  • Octapharma USA, Inc
  • Shire Plc
  • Takeda Pharmaceutical Company Ltd
  • ADMA Biologics, Inc

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Plasma Protein Therapeutics Market, report scope
• TABLE 2. Global Plasma Protein Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Plasma Protein Therapeutics Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
• TABLE 4. Global Plasma Protein Therapeutics Market estimates & forecasts by Application 2019-2029 (USD Billion)
• TABLE 5. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 7. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. U.S. Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 18. Canada Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 19. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 21. UK Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 22. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 24. Germany Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 25. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 27. France Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 28. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 30. Italy Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 31. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 33. Spain Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 34. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 36. RoE Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 37. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 39. China Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 40. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 42. India Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 43. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 45. Japan Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 46. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 48. South Korea Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 49. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 50. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 51. Australia Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 52. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 53. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 54. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 55. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 56. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 57. Brazil Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 58. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 59. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 60. Mexico Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 61. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 62. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 63. RoLA Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 64. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 65. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 66. Row Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 67. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 68. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 69. List of secondary sources, used in the study of global Plasma Protein Therapeutics Market
• TABLE 70. List of primary sources, used in the study of global Plasma Protein Therapeutics Market
• TABLE 71. Years considered for the study
• TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Plasma Protein Therapeutics Market, research methodology
• FIG 2. Global Plasma Protein Therapeutics Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Plasma Protein Therapeutics Market, key trends 2021
• FIG 5. Global Plasma Protein Therapeutics Market, growth prospects 2022-2029
• FIG 6. Global Plasma Protein Therapeutics Market, porters 5 force model
• FIG 7. Global Plasma Protein Therapeutics Market, pest analysis
• FIG 8. Global Plasma Protein Therapeutics Market, value chain analysis
• FIG 9. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Plasma Protein Therapeutics Market, regional snapshot 2019 & 2029
• FIG 15. North America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 17. Asia Pacific Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
• FIG 19. Global Plasma Protein Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Plasma Protein Therapeutics Market is valued at approximately USD 27.45 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2029. Plasma protein therapeutics is a biological medicine made up of plasma. It is a biological substance with a distinct chemical composition depending upon how it was produced and processed. The majority of blood is made up of plasma, contains water, salts, proteins, antibodies, and enzymes. The Plasma Protein Therapeutics market is expanding because of factors such as increasing incidence of immune deficiency disorder and surge in geriatric populations. Its prevalence has progressively increased during the last few years.

Plasma protein therapies are used in the treatment of various chronic, life-threatening, and genetic diseases. Its prevalence has progressively increased during the last few years. According to Statista, plasma demand around the world was expected to increase up to 50 million liters by 2020. Furthermore, in 2020, more than 1018.8 metric tons of albumin were consumed worldwide and projected to reach around 1125.5 metric tons by 2022. It is a global protein generated from blood plasma used for cancer diagnostics and therapies, and Morbus Wilson treatments. It is used mostly for cancer diagnostics and therapies. Another important component driving space is increasing geriatric populations. In 2022, Monaco was the country with the highest percentage of total population that was over the age of 65. Monaco has the oldest population in the world with 36 percent of Japanese over 65. Germany on the other hand has 22 percent of its population being over 65 in 2022. In addition Approximately 25% of the world's population is under 15, while 10% is over 65. The youngest population in the world is found in Africa. Indicating the low life expectancy in many nations, 40% of people on the continent are under the age of 15 and less than 4% are over 65. Contrarily, in Europe, a greater proportion of the population is over 65 than is under 15 years old. Furthermore, in 2021 Baxter International Inc. announced the global launch of PrisMax 2. It is designed to simplify delivery of continuous renal replacement therapy and organ support plasma therapies, while providing flexibility to meet the demands of the intensive care unit . The PrisMax 2 system features the company's TrueVue digital health portfolio, as well as the PrismaLung blood-gas exchanger that delivers extracorporeal carbon dioxide removal therapy to support acute respiratory dysfunction. However, the high cost of Plasma Protein Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Plasma Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the dominance of increase in healthcare expenditure. According to Statista, the Health Care segment of north America is projected to reach USD 20.77 billion in 2023 and expected to show an annual growth rate of 12.25% in between 2023 to 2027, resulting in a projected market volume of USD 32.97 billion by 2027.Furthermore, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing research and development related to plasma protein therapies in the market space.

Major market players included in this report are:

• Baxter International
• Biotest
• CSL Behring
• China Biologics
• GRIFOLS, S.A.
• Kedrion
• Octapharma USA, Inc
• Shire Plc
• Takeda Pharmaceutical Company Ltd
• ADMA Biologics, Inc

Recent Developments in the Market:

• In April 2020, Kedrion Biopharma collaborated with Kamada Ltd. For manufacturing, development, and distribution of a human plasma-derived Anti-SARS-CoV-2 (COVID-19) polyclonal immunoglobulin (IgG) product as a potential treatment for COVID-19 patients

Global Plasma Protein Therapeutics Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Product Type, Application, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

• C1 esterase Inhibitors
• Albumins
• Immunoglobulins
• Others

By Application:

• Hereditary Angioedema
• Hemophilia
• Primary Immunodeficiency Disorder
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Plasma Protein Therapeutics Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Plasma Protein Therapeutics Market, by Product Type, 2019-2029 (USD Billion)
  • 1.2.3. Plasma Protein Therapeutics Market, by Application, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Plasma Protein Therapeutics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Plasma Protein Therapeutics Market Dynamics

• 3.1. Plasma Protein Therapeutics Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing incidence of immune deficiency disorders
    • 3.1.1.2. Surge in geriatric populations
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Plasma Protein Therapeutics
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising investments in research and development programs by the pharmaceutical companies

Chapter 4. Global Plasma Protein Therapeutics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. Industry Experts Prospective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Plasma Protein Therapeutics Market, by Product Type

• 6.1. Market Snapshot
• 6.2. Global Plasma Protein Therapeutics Market by Product Type, Performance - Potential Analysis
• 6.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
• 6.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
  • 6.4.1. C1 esterase Inhibitors
  • 6.4.2. Albumins
  • 6.4.3. Immunoglobulins
  • 6.4.4. Others

Chapter 7. Global Plasma Protein Therapeutics Market, by Application

• 7.1. Market Snapshot
• 7.2. Global Plasma Protein Therapeutics Market by Application, Performance - Potential Analysis
• 7.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
• 7.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
  • 7.4.1. Hereditary Angioedema
  • 7.4.2. Haemophilia
  • 7.4.3. Primary Immunodeficiency Disorder
  • 7.4.4. Others

Chapter 8. Global Plasma Protein Therapeutics Market, Regional Analysis

• 8.1. Plasma Protein Therapeutics Market, Regional Market Snapshot
• 8.2. North America Plasma Protein Therapeutics Market
  • 8.2.1. U.S. Plasma Protein Therapeutics Market
    • 8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
    • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
  • 8.2.2. Canada Plasma Protein Therapeutics Market
• 8.3. Europe Plasma Protein Therapeutics Market Snapshot
  • 8.3.1. U.K. Plasma Protein Therapeutics Market
  • 8.3.2. Germany Plasma Protein Therapeutics Market
  • 8.3.3. France Plasma Protein Therapeutics Market
  • 8.3.4. Spain Plasma Protein Therapeutics Market
  • 8.3.5. Italy Plasma Protein Therapeutics Market
  • 8.3.6. Rest of Europe Plasma Protein Therapeutics Market
• 8.4. Asia-Pacific Plasma Protein Therapeutics Market Snapshot
  • 8.4.1. China Plasma Protein Therapeutics Market
  • 8.4.2. India Plasma Protein Therapeutics Market
  • 8.4.3. Japan Plasma Protein Therapeutics Market
  • 8.4.4. Australia Plasma Protein Therapeutics Market
  • 8.4.5. South Korea Plasma Protein Therapeutics Market
  • 8.4.6. Rest of Asia Pacific Plasma Protein Therapeutics Market
• 8.5. Latin America Plasma Protein Therapeutics Market Snapshot
  • 8.5.1. Brazil Plasma Protein Therapeutics Market
  • 8.5.2. Mexico Plasma Protein Therapeutics Market
  • 8.5.3. Rest of Latin America Plasma Protein Therapeutics Market
• 8.6. Rest of The World Plasma Protein Therapeutics Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Baxter International
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Biotest
  • 9.2.3. CSL Behring
  • 9.2.4. China Biologics
  • 9.2.5. GRIFOLS, S.A.
  • 9.2.6. Kedrion
  • 9.2.7. Octapharma USA, Inc
  • 9.2.8. Shire Plc
  • 9.2.9. Takeda Pharmaceutical Company Ltd
  • 9.2.10. ADMA Biologics, Inc

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption